Hitoshi Nakagama
- Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment 17
- MicroRNA in disease regulation 17
- Oncology top 0.5%
- Cancer-related Molecular Pathways 30
- PARP inhibition in cancer therapy 26
- Molecular Biology top 0.5%
- DNA Repair Mechanisms 40
- Metabolism, Diabetes, and Cancer 15
- Ubiquitin and proteasome pathways 13
-
- Genetic factors in colorectal cancer 18
- Immunology top 5%
- Co-authors
- Naoto TsuchiyaTakashi SügimuraMasaru KatohMasashi IzumiyaMinako NagaoHiroshi TazawaKeiji WakabayashiTakahiro Ochiya
- Journals
- Proceedings of the National Academy of Sciences (11 papers)Nucleic Acids Research (2 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Hitoshi Nakagama
217 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 3.9k
- Oncology 3.3k
- Molecular Biology 7.6k
- Pathology and Forensic Medicine 759
- Immunology 877
Countries citing papers authored by Hitoshi Nakagama
This map shows the geographic impact of Hitoshi Nakagama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Nakagama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Nakagama more than expected).
Fields of papers citing papers by Hitoshi Nakagama
This network shows the impact of papers produced by Hitoshi Nakagama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Nakagama. The network helps show where Hitoshi Nakagama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitoshi Nakagama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 43 | |
| 4 | 2020 | 60 | |
| 5 | [A Multi-Stakeholder Dialogue on Universal Health Coverage for Cancer in Asia - Seeking an Approach to Asia Health and Wellbeing Initiative]. | 2018 | 0 |
| 6 | 2018 | 85 | |
| 7 | 2017 | 40 | |
| 8 | Possible Involvement of Pancreatic Fatty Infiltration in Pancreatic Carcinogenesis | 2016 | 3 |
| 9 | 2015 | 58 | |
| 10 | 2014 | 8 | |
| 11 | 2012 | 93 | |
| 12 | 2011 | 101 | |
| 13 | 2010 | 248 | |
| 14 | 2008 | 151 | |
| 15 | A tobacco-specific carcinogen, NNK, enhances AOM/DSS-induced colon carcinogenesis in male A/J mice. | 2008 | 10 |
| 16 | 2007 | 36 | |
| 17 | 2007 | 103 | |
| 18 | 2003 | 9 | |
| 19 | 1995 | 145 | |
| 20 | 1986 | 2 |
About Hitoshi Nakagama
Hitoshi Nakagama is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 219 papers that have together received 11.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (40 papers), Cancer-related Molecular Pathways (30 papers), PARP inhibition in cancer therapy (26 papers), Genetic factors in colorectal cancer (18 papers), Carcinogens and Genotoxicity Assessment (17 papers), MicroRNA in disease regulation (17 papers), Metabolism, Diabetes, and Cancer (15 papers) and Ubiquitin and proteasome pathways (13 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (3.3k citations) and Molecular Biology (7.6k citations). Hitoshi Nakagama has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Naoto Tsuchiya, Takashi Sügimura, Masaru Katoh, Masashi Izumiya, Minako Nagao, Hiroshi Tazawa, Keiji Wakabayashi, Takahiro Ochiya, Hirokazu Fukuda and Mitsuko Masutani. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.